SU1106444A3 - Способ получени замещенных дибензооксепинов или их солей или оптических изомеров - Google Patents

Способ получени замещенных дибензооксепинов или их солей или оптических изомеров

Info

Publication number
SU1106444A3
SU1106444A3 SU813269597A SU3269597A SU1106444A3 SU 1106444 A3 SU1106444 A3 SU 1106444A3 SU 813269597 A SU813269597 A SU 813269597A SU 3269597 A SU3269597 A SU 3269597A SU 1106444 A3 SU1106444 A3 SU 1106444A3
Authority
SU
USSR - Soviet Union
Prior art keywords
dibenzo
dioxepin
chloro
general formula
ethylamine
Prior art date
Application number
SU813269597A
Other languages
English (en)
Russian (ru)
Inventor
Мален Шарль
Пуанян Жан-Клод
Original Assignee
Сьянс Юньон Э Ко (Фирма)
Сосьете Франсэз Де Решерш Медикаль (Фирма)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сьянс Юньон Э Ко (Фирма), Сосьете Франсэз Де Решерш Медикаль (Фирма) filed Critical Сьянс Юньон Э Ко (Фирма)
Application granted granted Critical
Publication of SU1106444A3 publication Critical patent/SU1106444A3/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D321/00—Heterocyclic compounds containing rings having two oxygen atoms as the only ring hetero atoms, not provided for by groups C07D317/00 - C07D319/00
    • C07D321/02—Seven-membered rings
    • C07D321/10—Seven-membered rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SU813269597A 1980-04-10 1981-04-09 Способ получени замещенных дибензооксепинов или их солей или оптических изомеров SU1106444A3 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8008023A FR2480283A1 (fr) 1980-04-10 1980-04-10 Nouveaux derives tricycliques, leurs procedes de preparation et leur utilisation comme medicament

Publications (1)

Publication Number Publication Date
SU1106444A3 true SU1106444A3 (ru) 1984-07-30

Family

ID=9240699

Family Applications (1)

Application Number Title Priority Date Filing Date
SU813269597A SU1106444A3 (ru) 1980-04-10 1981-04-09 Способ получени замещенных дибензооксепинов или их солей или оптических изомеров

Country Status (23)

Country Link
US (1) US4459306A (cg-RX-API-DMAC10.html)
EP (1) EP0041410B1 (cg-RX-API-DMAC10.html)
JP (1) JPS56158780A (cg-RX-API-DMAC10.html)
AR (1) AR229026A1 (cg-RX-API-DMAC10.html)
AT (1) ATE5257T1 (cg-RX-API-DMAC10.html)
AU (1) AU538054B2 (cg-RX-API-DMAC10.html)
CA (1) CA1181068A (cg-RX-API-DMAC10.html)
DD (1) DD158242A5 (cg-RX-API-DMAC10.html)
DE (1) DE3161358D1 (cg-RX-API-DMAC10.html)
DK (1) DK159981A (cg-RX-API-DMAC10.html)
ES (2) ES8306483A1 (cg-RX-API-DMAC10.html)
FI (1) FI811059A7 (cg-RX-API-DMAC10.html)
FR (1) FR2480283A1 (cg-RX-API-DMAC10.html)
GR (1) GR75194B (cg-RX-API-DMAC10.html)
IL (1) IL62622A (cg-RX-API-DMAC10.html)
MA (1) MA19113A1 (cg-RX-API-DMAC10.html)
NO (1) NO811229L (cg-RX-API-DMAC10.html)
NZ (1) NZ196774A (cg-RX-API-DMAC10.html)
OA (1) OA06779A (cg-RX-API-DMAC10.html)
PT (1) PT72833B (cg-RX-API-DMAC10.html)
SU (1) SU1106444A3 (cg-RX-API-DMAC10.html)
YU (1) YU92481A (cg-RX-API-DMAC10.html)
ZA (1) ZA812379B (cg-RX-API-DMAC10.html)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2094790B (en) * 1981-03-13 1985-10-09 Spofa Vereinigte Pharma Werke Tricycle compounds
ATE35262T1 (de) * 1982-09-30 1988-07-15 Merck Frosst Canada Inc 6h-dibenz(b,e)(1,4)oxathiepin-derivate und deren herstellung.
CN1079670C (zh) * 1994-03-02 2002-02-27 阿克佐诺贝尔公司 舌下或颊给药的药物组合物
JP4006796B2 (ja) 1997-11-17 2007-11-14 株式会社日立製作所 個人情報管理方法および装置
EP1554572B1 (en) 2001-07-25 2009-10-14 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US6683072B1 (en) 2003-02-04 2004-01-27 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of irritable bowel syndrome and nonulcer dyspepsia
US20050227961A1 (en) * 2004-04-08 2005-10-13 Vela Pharmaceuticals, Inc. Compositions and methods for treatment of neuropathic pain, fibromyalgia and chronic fatigue syndrome
CN101287411B (zh) 2005-04-28 2013-03-06 普罗秋斯生物医学公司 药物信息系统及其用途
EP2063905B1 (en) 2006-09-18 2014-07-30 Raptor Pharmaceutical Inc Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
KR101909711B1 (ko) 2009-05-06 2018-12-19 라보라토리 스킨 케어, 인크. 활성제-칼슘 포스페이트 입자 복합체를 포함하는 피부 전달 조성물 및 이들을 이용하는 방법
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN111377901A (zh) * 2018-12-27 2020-07-07 华东理工大学 一种缩酚酸环醚类化合物及其制备方法与用途
BR112023020979A2 (pt) * 2021-04-10 2023-12-12 Sunovion Pharmaceuticals Inc Moduladores de taar1 e de serotonina e composições farmacêuticas e métodos para usá-los

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1312891A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux 1.5-benzo-dioxépannes et leur préparation
BE613210A (fr) * 1961-01-30 1962-07-30 Geigy Ag J R Nouveaux benzo-dioxépannes et leur préparation
FR1312889A (fr) * 1962-01-29 1962-12-21 Geigy Ag J R Nouveaux benzo-dioxépannes et leur préparation
US3758528A (en) * 1970-03-13 1973-09-11 Science Union & Cie Tricyclic compounds
US3821249A (en) * 1970-03-13 1974-06-28 En Nom Collectif Science Union Dibenzothiazefin derivatives
US4039676A (en) * 1975-06-23 1977-08-02 Ciba-Geigy Corporation 2-piperidinoalkyl-1,4-benzodioxans
US4335122A (en) * 1981-03-18 1982-06-15 Hoechst-Roussel Pharmaceuticals Inc. Dihydro-dibenzoxepines-thiepines and -morphanthridones, compositions and use

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
1. Гетероциклические соединени . Под ред. Эльдерфилда. М., ИЛ, 1954, с. 6-16. 2.Вейганд-Хильгетаг. Методы эксперимента в органической химии. М., Хими , 1968, с. 22-52. 3.Гейлорд Н. Восстановление комплексными гидридами металлов. М., ИЛ, 1959, с. 340-447. 4.Бюлер К., Пирсон Д. Органические синтезы. М., Мир, 1973, ч. 1, с. 374г384. 5.Там же, с. 504-511. *

Also Published As

Publication number Publication date
NZ196774A (en) 1983-09-30
ES8400742A1 (es) 1983-11-16
PT72833B (fr) 1982-07-26
FI811059L (fi) 1981-10-11
MA19113A1 (fr) 1981-12-31
ZA812379B (en) 1982-04-28
GR75194B (cg-RX-API-DMAC10.html) 1984-07-13
FR2480283B1 (cg-RX-API-DMAC10.html) 1983-09-23
DK159981A (da) 1981-10-11
CA1181068A (fr) 1985-01-15
IL62622A (en) 1984-10-31
EP0041410A1 (fr) 1981-12-09
PT72833A (fr) 1981-05-01
ES519463A0 (es) 1983-11-16
ATE5257T1 (de) 1983-11-15
AR229026A1 (es) 1983-05-31
NO811229L (no) 1981-10-12
FR2480283A1 (fr) 1981-10-16
US4459306A (en) 1984-07-10
AU538054B2 (en) 1984-07-26
FI811059A7 (fi) 1981-10-11
ES500942A0 (es) 1983-06-01
JPS56158780A (en) 1981-12-07
ES8306483A1 (es) 1983-06-01
YU92481A (en) 1984-02-29
OA06779A (fr) 1982-12-31
AU6934081A (en) 1981-10-15
IL62622A0 (en) 1981-06-29
EP0041410B1 (fr) 1983-11-09
JPS6116394B2 (cg-RX-API-DMAC10.html) 1986-04-30
DD158242A5 (de) 1983-01-05
DE3161358D1 (en) 1983-12-15

Similar Documents

Publication Publication Date Title
SU1106444A3 (ru) Способ получени замещенных дибензооксепинов или их солей или оптических изомеров
DE69211994T2 (de) Lignan-analoge, ihre herstellung und hypolipidemische arzneimittel
EP0025192B1 (de) Substituierte Oxirancarbonsäuren, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende Arzneimittel
US4886835A (en) Alkadiene derivatives, their preparation, and pharmaceutical compositions containing them
US4596821A (en) Treatment of gray matter edema with 3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones
US4604403A (en) Use of substituted-3(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones for treating grey matter edema
US4634717A (en) Substituted-3-(2,3-dihydro-1H-inden-5-yl)-4-hydroxy-1H-pyrrole-2,5-diones, useful for treating persons with gray matter edema
EP0257921A2 (en) New 1,3-diaryl cyclopentanes and derivatives thereof as paf antagonists
CH655100A5 (fr) 1-cyclohexenyl-2-(hydroxy- ou chloro-)ethyl-pyrrolidine et procede pour sa preparation.
CH635573A5 (en) Process for preparing novel 1,2-dihydroxypropane derivatives
FI61310C (fi) Nytt foerfarande foer framstaellning av saosom ett laekemedel anvaendbar 5-metyl-1-fenyl-1,3,4,6-tetrahydro-5h-bens(f)-2,5-oxazocin
PL102604B1 (pl) Sposob wytwarzania fluoropochodnych kwasow alkanokarboksylowych
EP0198762B1 (fr) Dérivés d'acide dibenzo[be]oxépinne-acétique, leur préparation, et des médicaments les contenant
CH646694A5 (fr) Derives de la 3,4,5-trimethoxy cinnamoyle piperazine et leur procede de preparation.
CH628034A5 (en) Process for the preparation of new benzo[c]quinol-9-(8H)-ones
US20080249312A1 (en) Process for the preparation of 2-methylspiro(1,3-oxathiolane-5,3')quiniclidine
US5246966A (en) Substituted alkenoic acid and its derivatives
SU884568A3 (ru) Способ получени (арилалкил) алкановых кислот
NO139438B (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive seco-prostaglandiner
CH683340A5 (de) Verfahren zur Herstellung von 2,2-Dimethyl-5-(2,5-Dimethylphenoxy)-Pentansäure.
FR2649981A1 (fr) Derives de dihydropyrimidothiazine, leur procede de preparation et compositions pharmaceutiques les contenant
CA1197511A (fr) Haloalkyl-8-4h-¬1|-benzopyran-4-ones, et procede de preparation
WO1981003021A1 (en) Bis-hydroxybenzyl derivatives,processes for their preparation and pharmaceutical composition containing same
US4537979A (en) Alpha-substituted-alkylarylketals particularly useful for preparing alpha-arylalkanoic acids
JP3047582B2 (ja) トレオ−４−アルコキシ−５−（アリールヒドロキシメチル）−２（５ｈ）−フラノンの製造方法